Research and experimental development on natural sciences and engineering
EPIDEMICA AS
Revenue 2025
NOK 386,000
Operating profit
NOK 110,000
Equity
NOK 142,000
Incorporated
2021
Share capital
NOK 30,000
Key figures · 2025
Current ratio
6.22
Equity ratio
83.9%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 28.5% | |
| Net margin (%%) | 23.3% | |
| Return on assets (%%) | 64.9% | |
| Likviditet | ||
| Current ratio | 6.22 | |
| Working capital | 142k | |
| Soliditet | ||
| Equity ratio (%%) | 83.9% | |
| Debt-to-equity ratio | 0.19 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.